Skip to main content
Clinical Trials/NCT04151017
NCT04151017CompletedNot Applicable

Efficacy of Autologous Fibrin Glue Versus Suture for Conjuntival Autografting in Primary Pterygium Surgery: a Randomized Clinical Trials

Hospital de Clinicas de Porto Alegre1 site in 1 country64 target enrollmentStarted: June 12, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
64
Locations
1
Primary Endpoint
Pterygium Recurrence

Study Overview

Brief Summary

Pterygium is wing-shaped, vascular, fleshy growth that originates on the conjuntiva and that can spread to the corneal limbus and beyond The surgical exeresis with autologous conjunctival autograft technique is the treatment of choice. Commercially available fibrin glue has been used preferentially for graft fixation due to its benefits compared to sutures; However, its cost and the risk of inflammatory immune reaction limit the its use. There are few studies about autologous fibrin glue.

OBJECTIVE: To determine the efficacy of autologous fibrin glue preparation in patients undergoing pterygium resection surgery. To compare with autologous conjunctival graft fixation with suture.

This is a randomized clinical trial. Two patient groups will undergo pterygium excision surgery. Group 1 will have autologous conjunctival graft fixation with autologous fibrin glue and group 2 will have suture graft fixation using 10.0 mononylon. Early and late postoperative surgical results as well as complication rates will be analyzed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • nasal primary pterygium

Exclusion Criteria

  • relapsed pterygium
  • patients with a history of previous eye surgery
  • patients with glaucoma using hypotensive eye drops
  • eye surface diseases
  • eye allergy
  • diabetic patients,

Outcomes

Primary Outcomes

Pterygium Recurrence

Time Frame: 6 months

Recurrence in 6 months

Secondary Outcomes

  • Graft Edema(Postoperative day 1, 7, 21 and 30)
  • Postoperative Pain(Postoperative day 1, 7, 21 and 30)
  • Autograft Retraction(Postoperative day 1, 7, 21 and 30)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials